08:34 AM EST, 03/06/2025 (MT Newswires) -- NeuPath Health (NPTH.V), which operates pain management clinics, on Thursday said it performed the "first-ever" injection of Arthrosamid in North America at its Mississauga, Ontario clinic.

Before Health Canada's approval of Arthrosamid, patients would travel to Europe to access this hydrogel that has been shown to provide up to four years of pain relief for knee osteoarthritis sufferers, the company said.

"This is a major step forward in osteoarthritis options for Canadians," said NeuPath Chief Executive Joe Walewicz. "It underscores our commitment to provide best chronic pain care to our patients as we scale up our clinic network and expand our services across Canada."